Table 1.
Isolate | ST | KPC Variant | MIC (µg/mL)b | Log-Kill at 24 Hours in Presence of Meropenemc | ||||
---|---|---|---|---|---|---|---|---|
Ceftazidime-Avibactam | Ceftazidime | Meropenem | 4× MIC | 8× MIC | 16 µg/mL | |||
1-A | 258 | KPC-3 | 2 (S) | 512 | 128 | d | d | +3.53 |
1-B | 258 | D179Y, T243M | 256 | >512 | 0.5 (S) | −4.97 | −4.27 | −4.97 |
1-C | 258 | D179Y, T243M | 256 | >512 | 0.25 (S) | −5.94 | −4.94 | −5.96 |
2-A | 258 | KPC-3 | 4 (S) | 256 | 32 | d | d | +3.57 |
2-B | 258 | V240G | 32 | >512 | 8 | −6.14 | −6.14 | −6.14 |
2-C | 258 | D179Y | >256 | >512 | 4 | −4.64 | −5.64 | −4.64 |
3-A | 258 | KPC-3 | 2 (S) | 256 | 32 | d | d | +3.52 |
3-B | 258 | D179Y | 128 | 512 | 0.25 (S) | −5.98 | −5.98 | −5.98 |
3-C | 258 | D179Y | 64 | 512 | 0.125 (S) | −3.18 | −3.18 | −5.83 |
4-A | 258 | KPC-3 | 1 (S) | 256 | 16 | d | d | +3.52 |
4-B | 258 | A177E, D179Y | 256 | 256 | 0.25 (S) | −3.70 | −5.16 | −6.16 |
4-C | 258 | A177E, D179Y | 128 | 256 | 0.25 (S) | −3.26 | −2.54 | −5.96 |
Abbreviations: cfu, colony-forming units; CLSI, Clinical Laboratory Standards Institute; KPC, Klebsiella pneumoniae carbapenemase; MIC, minimum inhibitory concentration; S, susceptible based on CLSI interpretive criteria; ST, sequence type. Bolded rows represent the baseline isolate from each of the 4 patients.
aTime-kill assays were performed in duplicate for each isolate, using a 1 × 106 cfu/mL inoculum in cation-adjusted Mueller-Hinton broth. Bactericidal responses were defined as a ≥3-log decrease in cfu/mL from the starting inoculum at 24 hours.
bMICs were determined by broth microdilution according to reference methods (1). CLSI interpretative criteria were applied to define susceptibility as follows: ceftazidime-avibactam, ≤8 µg/mL; ceftazidime, ≤4 µg/mL; meropenem, ≤1 µg/mL.
cDifference in concentration (log10) compared with baseline (time 0). Data are shown for a representative replicate of each isolate.
dNot tested.